Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.50 |
| ▸ | ATM | Q13315 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 5/20 | 0.48 |
| ▸ | CA2 | P00918 | 5/20 | 0.48 |
| ▸ | CA9 | Q16790 | 5/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | THRB | P10828 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | CA12 | O43570 | 4/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | EGFR | P00533 | 2/20 | 0.40 |
| ▸ | ERBB2 | P04626 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13433889 | 0.79 | MAPK1 (0.55) | LMNASMN1; SMN2MAPK1ATMCA1 | |
| SCHEMBL28484741 | 0.79 | MAPK1 (0.56) | LMNASMN1; SMN2MAPK1ATMCA1 | |
| SCHEMBL28927428 | 0.78 | MAPK1 (0.51) | LMNASMN1; SMN2MAPK1ATMCA1 | |
| SCHEMBL9780860 | 0.77 | MAPK1 (0.50) | LMNASMN1; SMN2MAPK1ATMCA1 | |
| SCHEMBL811043 | 0.76 | MAPK1 (0.60) | LMNASMN1; SMN2MAPK1ATMCA1 | |
| SCHEMBL10401900 | 0.76 | MAPK1 (0.56) | LMNASMN1; SMN2MAPK1ATMCA1 | |
| SCHEMBL11518408 | 0.75 | ALDH1A1 (0.58) | LMNASMN1; SMN2MAPK1ATMCA1 | |
| SCHEMBL11521579 | 0.73 | MAPK1 (0.60) | LMNASMN1; SMN2MAPK1ATMCA1 | |
| SCHEMBL11492372 | 0.72 | ALDH1A1 (0.51) | LMNASMN1; SMN2MAPK1ATMCA1 | |
| SCHEMBL28354112 | 0.72 | MAPK1 (0.55) | LMNASMN1; SMN2MAPK1ATMCA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1455772-A | Preventive or remedial agent for allergic disease and medical water-based liquid preparation, eye drop and nasal drop | SHOEI CO LTD (JP) | 2003-11-12 | — | — | CN | disclosed |
| EP-1352903-A1 | PREVENTIVE OR REMEDIAL AGENT FOR ALLERGIC DISEASE AND MEDICAL WATER-BASED LIQUID PREPARATION, EYE DROP, AND NASAL DROP | SHOEI CO., LTD. (JP) | 2003-10-15 | — | — | EP | disclosed |
| US-20030144335-A1 | Preventive or remedial agent for allergic disease and medical water-based liquid preparation, eye drop, and nasal drop | SHOEI CO., LTD. (JP) | 2003-07-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030144335-A1 | Preventive or remedial agent for allergic disease and medical water-based liquid preparation, eye drop, and nasal drop | NOS1, NNT, NOS2 | LMNA 2747/4885SMN1; SMN2 1427/4885MAPK1 749/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.